ArticleEpilepsia2020

Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: A phase 1, open-label study.

Robert Edward Hogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.